These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3076451)

  • 1. Conformational effects of the substitution of Arg for Gly 13 in the ras oncogene-encoded P21 protein.
    Brandt-Rauf PW; Carty RP; Carucci J; Avitable M; Lubowsky J; Pincus MR
    J Protein Chem; 1988 Aug; 7(4):349-54. PubMed ID: 3076451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational effects of amino acid substitutions at positions 10, 12, and 13 in the P21 protein.
    Brandt-Rauf PW; Pincus MR; Carty RP; Lubowsky J; Avitable M; Kung HF; Maizel J
    J Protein Chem; 1989 Feb; 8(1):79-86. PubMed ID: 2669815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the low energy conformations of an oncogenic and a non-oncogenic p21 protein, neither of which binds GTP or GDP.
    Liwo A; Gibson KD; Scheraga HA; Brandt-Rauf PW; Monaco R; Pincus MR
    J Protein Chem; 1994 Feb; 13(2):237-51. PubMed ID: 8060496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the computed structures for the phosphate-binding loop of the p21 protein containing the oncogenic site Gly 12 with the X-ray crystallographic structures for this region in the p21 protein and EFtu. A model for the structure of the p21 protein in its oncogenic form.
    Chen JM; Lee G; Murphy RB; Carty RP; Brandt-Rauf PW; Friedman E; Pincus MR
    J Biomol Struct Dyn; 1989 Apr; 6(5):859-75. PubMed ID: 2686707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural effects of substitutions on the p21 proteins.
    Pincus MR; Brandt-Rauf PW
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3596-3600. PubMed ID: 3923480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen.
    Ni F; Konishi Y; Bullock LD; Rivetna MN; Scheraga HA
    Biochemistry; 1989 Apr; 28(7):3106-19. PubMed ID: 2742828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational effects of substituting amino acids for glutamine-61 on the central transforming region of the P21 proteins.
    Pincus MR; Brandt-Rauf PW; Carty RP; Lubowsky J; Avitable M; Gibson KD; Scheraga HA
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8375-9. PubMed ID: 3120190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the computed three-dimensional structures of oncogenic forms (bound to GDP) of the ras-gene-encoded p21 protein with the structure of the normal (non-transforming) wild-type protein.
    Monaco R; Chen JM; Chung D; Brandt-Rauf P; Pincus MR
    J Protein Chem; 1995 Aug; 14(6):457-66. PubMed ID: 8593186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the conformation and GTP hydrolysing ability of N-terminal ras p21 protein segments.
    Niu CH; Han KH; Roller PP
    Biochem Biophys Res Commun; 1989 Apr; 160(1):282-8. PubMed ID: 2785386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
    Pullano TG; Sinn E; Carney WP
    Oncogene; 1989 Aug; 4(8):1003-8. PubMed ID: 2474786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.
    Zhang S; Bagshaw R; Hilson W; Oho Y; Hinek A; Clarke JT; Callahan JW
    Biochem J; 2000 Jun; 348 Pt 3(Pt 3):621-32. PubMed ID: 10839995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated conformations of the ras-gene-encoded p21 protein. 2. Comparison of the computed and high-resolution x-ray crystallographic structures of Gly-12 p21.
    Dykes DC; Brandt-Rauf P; Luster SM; Friedman FK; Pincus MR
    J Biomol Struct Dyn; 1993 Apr; 10(5):905-18. PubMed ID: 8318164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln-->Leu61).
    Gedde-Dahl T; Spurkland A; Eriksen JA; Thorsby E; Gaudernack G
    Int Immunol; 1992 Nov; 4(11):1331-7. PubMed ID: 1282032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules.
    Krengel U; Schlichting I; Scherer A; Schumann R; Frech M; John J; Kabsch W; Pai EF; Wittinghofer A
    Cell; 1990 Aug; 62(3):539-48. PubMed ID: 2199064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of new anti-cancer peptides from conformational energy analysis of the oncogenic ras-p21 protein and its complexes with target proteins.
    Pincus MR
    Front Biosci; 2004 Sep; 9():3486-509. PubMed ID: 15353372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated conformations of the ras-gene-encoded p21 protein. 1. An energy-refined structure for the normal p21 protein complexed with GDP.
    Dykes DC; Brandt-Rauf P; Luster SM; Chung D; Friedman FK; Pincus MR
    J Biomol Struct Dyn; 1992 Jun; 9(6):1025-44. PubMed ID: 1637501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics of the H-ras gene-encoded p21 protein; identification of flexible regions and possible effector domains.
    Dykes DC; Friedman FK; Dykes SL; Murphy RB; Brandt-Rauf PW; Pincus MR
    J Biomol Struct Dyn; 1993 Dec; 11(3):443-58. PubMed ID: 8129867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of ras oncogenes by analysis of p21 proteins in human tumor cell lines.
    Fujita J; Yoshida O; Ebi Y; Nakayama H; Onoue H; Rhim JS; Kitamura Y
    Urol Res; 1988; 16(6):415-8. PubMed ID: 3068879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural differences between a ras oncogene protein and the normal protein.
    Tong LA; de Vos AM; Milburn MV; Jancarik J; Noguchi S; Nishimura S; Miura K; Ohtsuka E; Kim SH
    Nature; 1989 Jan; 337(6202):90-3. PubMed ID: 2642607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlapping epitopes encompassing a point mutation (12 Gly-->Arg) in p21 ras can be recognized by HLA-DR, -DP and -DQ restricted T cells.
    Fossum B; Gedde-Dahl T; Hansen T; Eriksen JA; Thorsby E; Gaudernack G
    Eur J Immunol; 1993 Oct; 23(10):2687-91. PubMed ID: 7691613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.